Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Disordering of Human Telomeric G-Quadruplex with Novel Antiproliferative Anthrathiophenedione

  • Dmitry Kaluzhny ,

    Affiliation Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation

  • Nikolay Ilyinsky,

    Affiliation Moscow Institute of Physics and Technology, Dolgoprudny, Russian Federation

  • Andrei Shchekotikhin,

    Affiliation Gause Institute of New Antibiotics, Russian Academy of Medical Sciences, Moscow, Russian Federation

  • Yuri Sinkevich,

    Affiliation Mendeleyev University of Chemical Technology, Moscow, Russia

  • Philipp O. Tsvetkov,

    Affiliation Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation

  • Vladimir Tsvetkov,

    Affiliation Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russian Federation

  • Alexander Veselovsky,

    Affiliation Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russian Federation

  • Mikhail Livshits,

    Affiliation Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation

  • Olga Borisova,

    Affiliation Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation

  • Alexander Shtil,

    Affiliation Blokhin Cancer Center, Russian Academy of Medical Sciences, Moscow, Russian Federation

  • Anna Shchyolkina

    Affiliation Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation

Disordering of Human Telomeric G-Quadruplex with Novel Antiproliferative Anthrathiophenedione

  • Dmitry Kaluzhny, 
  • Nikolay Ilyinsky, 
  • Andrei Shchekotikhin, 
  • Yuri Sinkevich, 
  • Philipp O. Tsvetkov, 
  • Vladimir Tsvetkov, 
  • Alexander Veselovsky, 
  • Mikhail Livshits, 
  • Olga Borisova, 
  • Alexander Shtil


Linear heteroareneanthracenediones have been shown to interfere with DNA functions, thereby causing death of human tumor cells and their drug resistant counterparts. Here we report the interaction of our novel antiproliferative agent 4,11-bis[(2-{[acetimido]amino}ethyl)amino]anthra[2,3-b]thiophene-5,10-dione with telomeric DNA structures studied by isothermal titration calorimetry, circular dichroism and UV absorption spectroscopy. New compound demonstrated a high affinity (Kass∼106 M−1) for human telomeric antiparallel quadruplex d(TTAGGG)4 and duplex d(TTAGGG)4∶d(CCCTAA)4. Importantly, a ∼100-fold higher affinity was determined for the ligand binding to an unordered oligonucleotide d(TTAGGG TTAGAG TTAGGG TTAGGG unable to form quadruplex structures. Moreover, in the presence of Na+ the compound caused dramatic conformational perturbation of the telomeric G-quadruplex, namely, almost complete disordering of G-quartets. Disorganization of a portion of G-quartets in the presence of K+ was also detected. Molecular dynamics simulations were performed to illustrate how the binding of one molecule of the ligand might disrupt the G-quartet adjacent to the diagonal loop of telomeric G-quadruplex. Our results provide evidence for a non-trivial mode of alteration of G-quadruplex structure by tentative antiproliferative drugs.


The anthraquinone-containing antibiotics and their analogues are among the most efficacious antitumor drugs (see [1][3] for recent reviews). The formation of drug-DNA complexes is the established mechanism of cytotoxicity of anthraquinone derivatives [4][8]. The binding of small molecules to different DNA structures results in DNA damage and interference with DNA dependent enzymes, eventually leading to cell death. A series of 1,4- and 2,6-difunctionalized amidoanthracene-9,10-diones have been shown to inhibit human telomerase via stabilization of telomeric G-quadruplex structures [9], [10]. Guanine quadruplexes (G-quadruplexes) are formed via an association of four guanines into a cyclic Hoogsteen hydrogen bonding arrangement in which each guanine shares two hydrogen bonds with its neighbor (N1–O6 and N2–N7) [11]. The G-quartets formed by single strand telomeric sequence may regulate telomerase activity: the intramolecular G-quadruplexes block telomerase activity in vitro [12], [13]. The derivatives of anthracene-9,10-diones substituted at the positions 1,5, 1,8 and 2,7 formed 1∶1 end-capping complexes with human telomeric G-quadruplex and also effectively inhibited telomerase [14].

The emergence of drug resistance as well as organ toxicity may hamper the clinical efficacy of anthraquinone-based drugs [15][17]. Aiming at agents with improved chemotherapeutic properties, a series of linear heteroareneanthracenediones has been synthesized [18]. Some compounds of this chemotype showed a marked antiproliferative efficacy, in particular, a remarkable potency against cell lines with the determinants of drug resistance such as P-glycoprotein or p53 dysfunction. Besides, within the series of anthra[2,3-b]thiophene-5,10-dione we identified bis(guanidine) derivative (compound 1; Fig. 1A) as a potent inhibitor of polydeoxynucleotide synthesis in TRAP assay [19]. One may suggest that strong basicity and delocalization of charges in the guanidine groups of side chains attributed to this effect.

Figure 1. Structures of anthra[2,3-b]thiophene-5,10-diones 1 and 2 (A); oligonucleotides used in the study (B).

However, it was difficult to determine the affinity of 1 to DNA structures due to poor water solubility and aggregation of the compound at physiological temperature, pH and ionic strength of buffers. To avoid these obstacles we prepared a novel analogue of 1 in which both guanidine groups in the side chains were substituted for acetamidines. This modification retained the basicity and the characteristic delocalization of terminal cationic centers in the side chains and improved the physical properties of the ligand. In the present study we report the binding of this novel anthrathiophenedione derivative, 4,11-bis[(2-{[acetimido]amino}ethyl)amino]anthra[2,3-b]thiophene-5,10-dione (compound 2; Fig. 1A) to telomeric DNA duplex, telomeric G-quadruplex d(TTAGGG)4 (TelQ) and the mutant G11A oligonucleotide d(TTAGGG TTAGAG TTAGGG TTAGGG) (TelM) (Fig. 1B) unable to form quadruplex structures in the presence of Na+ [20]. Two conformations of intramolecular TelQ were studied∶ antiparallel G-quadruplex TelQNa formed in the presence of Na+ and a ‘3+1’ hybrid G-quadruplex conformation (TelQK) that can be stabilized by K+ counterions [21]. We found a high affinity of 2 to DNA structures, with a ∼100-fold preference for G-containing unordered DNA in the presence of Na+. Moreover, the addition of 2 to the antiparallel G-quadruplex in the presence of Na+ led to circular dichroism (CD) and UV absorption spectral changes compatible with nearly complete unfolding of the antiparallel quadruplex conformation. Partial unfolding of TelQK by 2 occurred in the presence of K+. Molecular dynamics simulations illustrated a mode of TelQNa disordering by 2.

Results and Discussion

Synthesis and cytotoxicity of compound 2

Similarly to the previously reported compound 1 [19], the synthesis of 2 was performed by modification of side chains in 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]thiophene-5,10-dione (compound 3 in Scheme S1) by amidation of terminal amino groups with ethyl acetimidate hydrochloride (Scheme S1; see Section S1 for details). After this modification of the side chains of 1 the basicity and the characteristic delocalization of terminal cationic centers in 2 remained unaltered. However, this modification diminished the polarity, increased the water solubility and decreased the intermolecular association of molecules of 2 in aqueous solutions. Testing of antiproliferative potency revealed that 2 inhibited the viability of leukemia (L1210, Molt4/C8, CEM, K562) and colon carcinoma HCT116 cell lines at micromolar concentrations after 72 h of exposure (IC50, a concentration that inhibited cell viability by 50%, was 5–10 µM as determined by MTT-test [19]. Importantly, 2 was similarly potent against the sublines otherwise resistant to structurally related antitumor DNA intercalator doxorubicin due to expression of the transmembrane transporter P-glycoprotein or deletion of p53 [19]. These data suggested that the modification of the side chain in 1 yielded the compound with promising anticancer characteristics. We set out to investigate the interaction of 2 with various DNA structures.

Thermodynamic parameters of DNA:2 complex formation

The interactions of 2 with duplex DNA (Fig. 1B) as well as with quadruplex–forming oligonucleotide TelQ and the oligonucleotide TelM (unable to fold in an intramolecular quadruplex) were studied with isothermal titration calorimetry (ITC) in the presence of NaCl or KCl (Fig. S1). The thermodynamic parameters are presented in Table 1. Compound 2 binds to double stranded DNA with Kass = 2.2±0.1·106 M−1, with the stoichiometry N1 = 5–6 molecules per 24 bp telomeric duplex. Up to three molecules of 2 can bind to the antiparallel G-quadruplex d(TTAGGG)4 in the presence of NaCl (TelQNa) with Kass∼106 M−1. In the presence of NaCl the unordered oligonucleotide TelM binds 2 much stronger (Kass = 2.0±0.7·108 M−1 for one molecule and Kass∼5.7·106 M−1 for the next six molecules; Table 1). KCl ensures a tight ligand binding to TelQK (Kass = 1.0±0.15·107 M−1) with the maximal number of binding sites N = 7. The thermodynamic profiles of binding of 2 to dsDNA, TelM and TelQ (Table 1) in most cases corresponded to the induced-fit mechanism. A large favorable enthalpy contribution and a rather modest, though significant, unfavorable entropic contribution to the binding free energy are characteristic for the coupling of ligand binding to a major conformational change in DNA creating a stable binding pocket [22]. The entropic gain at the binding of 2 to dsDNA should be due to the effect of hydrophobic transfer. The CD spectra of dsDNA indicate a decreased base stacking interaction upon the ligand binding (Fig. S2). We anticipate that 2 semi-intercalates into dsDNA while the bulky groups are located in the duplex groove(s). The difference between TelQNa and TelQK in the strength of binding to 2 is due to the difference in the losses of entropy associated with various degrees of conformational changes of the quadruplexes. TelQK is likely to undergo incomplete conformational change. Thus, two modes of binding of 2 to TelM were revealed, suggesting that the one site of stronger, enthalpy driven binding is the intercalation site whereas about six weaker ones with nearly null entropic component correspond to external binding.

Drug-TelQNa interaction monitored by circular dichroism

The CD spectrum of TelQNa is shown in Fig. 2A, open circles. The CD curve in the presence of Na+ reflects the folding of the oligonucleotide into an antiparallel G-quadruplex with two edgewise loops and a diagonal loop [21], [23]. The addition of 2 up to 6 µM dramatically changed the CD spectra (Fig. 2A, filled circles). Importantly, upon the binding of the ligand to the quadruplex structure no CD induction in the region of absorption of 2 (450–700 nm) was detectable. We assume that the ligand-associated CD changes below 320 nm reflected DNA conformational changes rather than CD induction. The magnitudes of the positive CD band centered at 295 nm and the negative band at 265 nm decreased (Fig. 2A). We next compared the CD spectrum of TelQNa:2 complex (Fig. 2A, filled circles) with CD spectra of TelQNa denatured by high temperature. Strikingly, the CD spectrum of the markedly denatured G-quadruplex at 60°C (Fig. 2B, triangles) was similar to the CD of TelQNa:2 complex (Fig. 2A, filled circles). The unfolding was almost complete after the addition of three ligand molecules per TelQNa (Fig. 2A, INSET), in agreement with the maximal number of bound ligand molecules determined by ITC (Table 1). Thus, the CD data suggested that the binding of 2 to the antiparallel TelQNa is accompanied by a significant unfolding of the TelQNa. This suggestion is strengthened by data on thermal denaturation of TelQNa and TelQNa:2 monitored by absorption at λ = 295 nm (see below).

Figure 2. CD spectra of TelQ.

(A) CD spectra of TelQ at various concentrations of 2. INSET: CD magnitudes at 295 nm (filled circles) and 265 nm (triangles). The concentration of TelQ oligonucleotide was 0.8 µM, the ratios of concentrations compound 2 to TelQ are given on the X axis (INSET). T = 20°C. (B) CD spectra of TelQ at 20°C (open circles), 30°C, 40°C, 50°C, 60°C (triangles), 75°C (filled circles). Samples contained 100 mM NaCl, 10 mM Na phosphate buffer, pH 7.6.

Disruption of TelQNa structure by compound 2

The UV melting of TelQNa in the presence of 2 monitored by absorption at λ = 295 nm is shown in Fig. 3. This wavelength is particularly suitable for detection of quadruplexes because absorption at λ = 295 nm reflects the presence of G-quartets [24]. The melting profile for TelM (open squares) demonstrated the absence of a G-quartet structure in the range of temperatures 20°–90°C [20]. The melting experiment shows a decreased absorption at 295 nm at 20°C upon the addition of 1 µM of 2 to TelQNa, indicating a partial loss of G-quartet structure (Fig. 3, triangles). After the addition of 6 µM of 2 the quadruplex conformation of TelQNa was abolished at 20°C (Fig. 3, filled circles). Upon heating up to 55–60°C, the melting curve for TelQNa:2 complex became indistinguishable from that for free (no ligand) TelQNa (Fig. 3, open circles). Apparently, 2 dissociates from the oligonucleotide during heating; the complete DNA clearance occurs at >55–60°C. As a result, a fraction of G-quadruplexes is restored at these temperatures followed by complete quadruplex denaturation at >80–90°C. Thus, the absorption data independently confirmed the loss of G-quartets in TelQNa:2 complexes in the presence of Na+. We emphasize that the term ‘disordering’ of the studied TelQNa implies complete loss of G-quartets. Furthermore, interactions between all bases in TelQNa structure significantly decreased upon binding of 2 as revealed with CD (Fig. 2A). The conformation of the sugar-phosphate backbone in the ‘disordered’ state remains to be determined.

Figure 3. Thermal denaturation profiles of TelQNa and TelM.

The temperature induced changes in absorption at 295 nm of TelQNa and TelM at difenent concentrations of compound 2. Concentrations: TelQ was 1 µM, compound 2: 0 (open circles), 1 µM (triangles) and 6 µM (filled circles). Samples contained 100 mM NaCl, 10 mM Na phosphate buffer, pH 7.6. The absorption of compound 2 was subtracted from the absorption of the sample at 295 nm. TelQ, open circles; TelM, open squares.

Comparison of TelQNa:2 and TelM:2 complexes demonstrated differential affinity of the ligand to these oligonucleotides; the maximal number of bound molecules of 2 also differed (Table 1). In contrast to TelQNa, the conformation of free TelM oligonucleotide under the conditions of our experiments (DNA concentrations, ionic strength of buffers, room temperature) was represented predominantly by a single DNA strand with a few hydrogen bonds between nucleotides (Fig. S3). The addition of 2 led to the formation and/or stabilization of a conformation, most likely of an imperfect TelM hairpin, with a high affinity intercalation site for 2 (Kass≈2·108 M−1) (Table 1). The saturated TelM:2 complex presumably includes a TelM hairpin with two tightly intercalated and five externally bound drug molecules probably located at the stem of the TelM hairpin. This conclusion is consistent with ITC data (see section Thermodynamic parameters of DNA:2 complex formation). This consideration allows us to suggest that the effect of 2 on the single stranded telomeric DNA may directly depend on the propensity of the nucleotide sequence to form a quadruplex or a hairpin. In the former case, the DNA bound to 2 is disordered whereas in the latter scenario, the DNA stretch folds into a hairpin stabilized by the intercalating ligand. In other words, 2 can evoke a dual effect on DNA structure, that is, to break the quadruplex and to stabilize the hairpins.

Interaction of compound 2 with TelQK

In the presence of KCl the affinity of 2 to TelQK (Kass∼107 M−1) and the maximal number of bound molecules of 2 (N = 7) were much greater than the respective values for TelQNa (Table 1). The CD spectrum in 100 mM KCl revealed a ‘3+1’ folding of TelQK (Fig. 4, open circles) [25]. Three ‘strands’ of this intramolecular fold run parallel to one another, while the fourth ‘strand’ is antiparallel [26]. Theoretical calculations of the CD spectrum [25] identified the stacking mode of three G-quartets, two of which stack with the same polarity whereas the third one stacks with different polarity, independently proving the mode of quadruplex folding suggested by NMR [26]. The addition of 2 to TelQK resulted in another shape of CD signal of the quadruplex (Fig. 4, filled circles). This spectrum is compatible with an antiparallel G-quadruplex, where the quartets stack with different polarities [25]. UV melting experiments shed light on G-quadruplex conformational changes upon ligand binding (see below).

Figure 4. Circular dichroism spectra of TelQ at various concentrations of compound 2 in the presence of 0.1 M KCl.

INSET: CD magnitudes at 295 nm (filled circles) and 265 nm (triangles). The concentration of TelQ oligonucleotide was 1 µM, the ratios of concentrations compound 2 to TelQ are given on the X axis (INSET). T = 20°C. Samples contained 100 mM KCl, 10 mM Na phosphate buffer, pH 7.6.

Compound 2 causes partial disorganization of TelQK

We monitored the temperature dependence of TelQK absorption at 295 nm at different concentrations of 2 in the presence of 100 mM KCl (Fig. 5). At equal or close molar ratios TelQK:2 the absorption at 295 nm decreased, which normally indicates partial loss of G-quartets (Fig. 5, triangles and circles, respectively). Further increase of concentration of 2 led to opalescence of the sample that prevented reliable measurements. Probably, certain intermolecular interactions or drug aggregation at higher concentrations occurred in the presence of KCl, thereby causing light scattering. Thus, the absorption method provided evidence that, in the presence of 2 and KCl, at least a portion of the G-quartets in TelQK became disordered. The CD spectrum of the saturated complex TelQK:2 (Fig. 4, filled circles) is consistent with the presence of two quartets with different polarities [25], whereas the third G-quartet of the TelQK oligonucleotide may be broken upon ligand binding. The loss of the quartet that stacked with the same polarity as the neighboring quartet may account for the observed decrease of the CD signal around 260–265 nm (Fig. 4, INSET, triangles).

Figure 5. Thermal denaturation profiles of TelQK in the presence compound 2.

Concentrations: TelQ 1 µM; compound 2: 0 (open circles), 1 µM (triangles) and 2 µM (filled circles). Samples contained 0.1 M KCl, 10 mM Na phosphate buffer, pH 7.6. The contribution of compound 2 to the absorption of the sample at 295 nm was subtracted.

Partial disordering of TelQK conformation by 2 was further substantiated by the thermodynamic parameters of TelQK:2 complex (see Thermodynamic parameters of DNA:2 complex formation). The loss of the G-quartet structure should result in lengthening of the loops that connect two remaining G-quartets. One loop may acquire single nucleotide (guanine) whereas two additional guanines would be added to another loop (see the structure in [26]). The single strand loops might be good candidates for binding to 2 (Table 1). Stabilization of the antiparallel ‘3+1’ TelQK in the presence of K+ counterions [27] is likely to preclude drug-induced disruption of the quadruplex conformation.

Computer modeling of binding of 2 to TelQNa

Fig. 6A shows the results of docking of 2 to the rigid structure of TelQNa ([28], PDB ID: 143D). The position of the ligand with the lowest energy was selected for molecular dynamics simulations. The results obtained after 7 nsec of simulation of the complex TelQNa:2 demonstrated that even the binding of one molecule of 2 disrupted the G-quartet adjacent to the diagonal loop (Fig. 6B). Despite the loss of this G-quartet the sugar-phosphate backbone remained unaltered. The positioning of a highly hydrophobic tetracyclic backbone in 2 is the most favorable inside the cavity of the quadruplex. This fact, as well as limited space for capping due to the size and geometry of 2, might explain the disruption of the G-quartet by this ligand. The side chains in 2 provide the orientation of the ligand inside the cavity and displacement of guanines from the G-quartet plane. These simulations are in good agreement with our experimental data that strongly suggested that 2 forms high affinity complexes with the telomeric G-quadruplex, and this process involves disruption of the G-quartets.

Figure 6. A model of the complex of compound 2 with antiparallel TelQ.

(A) Docking of 2 to TelQNa. (B) The snapshot after the initial 7 nsec of molecular dynamics simulations. Compound 2 is rendered in light brown color; blue, red and green are the guanines of TelQ. The water accessible surface is shown. Colors are given according to an increase in log P values from brown to blue.

In summary, the novel compound 4,11-bis[(2-{[acetimido]amino}ethyl)amino]anthra[2,3-b]thiophene-5,10-dione (2) demonstrated a high affinity (Kass≈106–108 M −1) to double helical DNA, TelQ and an unordered TelM oligonucleotide. The binding of the ligand to these DNA targets may exert biological effects on cell functions and survival. Intercalation into dsDNA may lead to inhibition of template synthesis, thereby impeding gene expression and function of DNA dependent enzymes. These effects are common for many analogues of anthracene-9,10-diones [19]. Apart from the intercalation into dsDNA, we found a preference of 2 to unordered DNA conformation. Compound 2 disorders the intramolecular quadruplex conformation rather than stabilizing the quadruplex. Thus, 2 may exert a remarkable effect on G-containing strands present in the promoter regions of oncogenes. These sequences are involved in gene regulation via G-quadruplex formation, impeding recruitment of proteins necessary for gene expression [29], [30]. The antiproliferative activity of 2 may also be associated with tight binding to the G-forming sequences and competing with binding of regulatory proteins to DNA. In vitro, the d(TTAGGG)4 sequence is able to fold into two major G-quadruplex forms depending on the type of a counterion and designated in the study as TelQNa and TelQK. The DNA environment in the nucleus also includes proteins, low molecular substances and a significant local dehydration. Which G-quadruplex form, TelQNa or TelQK, of the telomeric sequence is realized in vivo, if any, has not been proven so far. Design of telomeric DNA ligands aimed at stabilization of G-quadruplex has been reported in the literature [29], [30], and some G-quadruplex stabilizers proved to be efficient antiproliferative agents. Our data suggest a non-trivial explanation of antiproliferative efficacy of the drug, that is, a competition of the ligand with cellular proteins for binding to the telomeric ssDNA rather than G-quadruplex stabilization. One can suppose that the ability to deorganize DNA quadruplexes may be potentially valuable anticancer property of anthrathiophenedione derivatives.

Materials and Methods


The oligonucleotides d(TTAGGG)4 (TelQ), d(TTAGGGTTAGAG(TTAGGG)2) (TelM) and d(CCCTAA)4:d(TTAGGG)4 (ds DNA) were synthesized by Syntol (Moscow). The DNA preparations were dissolved in the buffers containing 10 mM sodium phosphate supplemented with 100 mM NaCl or 100 mM KCl, pH 6.5 or 7.6. 4,11-Bis[(2-{[acetimido]amino}ethyl)amino]anthra[2,3-b]thiophene-5,10-dione dihydrochloride (compound 2) was dissolved in dimethylsulfoxide as 10 mM stock solution and kept at 4°C. Aqueous solutions of 2 were prepared immediately before the experiments.

Spectral methods

UV absorption spectra were acquired with a Jasco V-550 spectrophotometer (Japan). CD spectra were recorded on a Jasco 715 spectropolarimeter (Japan). The instruments were equipped with Peltier thermostated cell holders. Molar dichroism (Δε) was calculated per mole of nucleotides.

Isothermal titration calorimetry

The thermodynamic parameters of binding of 2 to oligonucleotides were measured using an iTC200 instrument (MicroCal, Northampton, MA). Experiments were carried out at 25°C in 100 mM NaCl or 100 mM KCl, 10 mM sodium phosphate buffer, pH 6.5. Two microliter aliquots of solution of 2 were injected into a 200 µl calorimetric cuvette containing the oligonucleotide solution to achieve the complete binding isotherm. The concentrations of oligonucleotides in the cell were 1.5–5 µM; the concentration of 2 in the syringe ranged from 100 to 200 µM. The heat of dilution was measured by injecting the solution of 2 into the buffer. The obtained values were subtracted from the heat of reaction to obtain the effective heat of binding. The resulting titration curves were fitted using ‘two set of sites’ model on MicroCal Origin software. Thus, the association constant Kass, enthalpy changes ΔH and stoichiometry N were determined. The entropy variation (ΔS) was calculated according to the standard thermodynamic equation.

Molecular modeling

The coordinates of the atomic positions of TelQ were taken from NMR (PDB ID: 143D). The model of compound 2 was created using SYBYL 8.0 molecular modeling package (Tripos Inc., St. Louis, USA). To define the most probable binding site for 2 in TelQ, the procedure of flexible ligand docking to the full surface of a rigid G-quadruplex was performed using DOCK 6.4 and the Anchor-and-Grow algorithm. The best docking pose was selected based on secondary scoring function of DOCK 6.4. The follow-up analysis of the ligand's influence on G-quadruplexes was performed using the molecular dynamics (MD) simulation with the application of a suite of programs Amber 8 in implicit solvent using general Born model. The MD simulations in the production phase were carried out using constant pressure on a trajectory of 10 ns with 2 fs step. For more details of molecular docking and MD simulation see Section S2.

Supporting Information

Section S1.

Synthesis of 4,11-bis[(2-{[acetimido]amino}ethyl)amino]anthra[2,3-b]thiophene-5,10-dione dihydrochloride (compound 2).



Scheme S1.

Synthesis of 4,11-bis[(2-{[acetimido]amino}ethyl)amino]anthra[2,3-b]thiophene-5,10-dione (2).



Section S2.

Molecular modeling.



Figure S1.

Isothermal titration calorimetry of DNA:2 complexes.



Figure S2.

CD spectra of the telomeric duplex d(TTAGGG)4:d(CCCTAA)4 at various concentrations of 2.



Figure S3.

CD spectra of TelM:2 complexes.




The authors are grateful to Yu. Luzikov, A. Korolev and M. Resnikova for NMR, HRMS and HPLS analyses, and to V. Florentiev for helpful discussion.

Author Contributions

Conceived and designed the experiments: DK A. Shchekotikhin A. Shchyolkina. Performed the experiments: DK. Analyzed the data: A. Shtil A. Shchekotikhin A.Shchyolkina. Wrote the paper: A. Shchyolkina. Performed the spectroscopic experiments: NI. Performed the ITC experiment: PT. Molecular docking and dynamics: VT. Analyzed the spectroscopy data: DK OB. Analyzed the molecular modeling: VT AV. Analyzed the thermodynamics: POT ML. Contributed reagents/materials/analysis tools-Chemistry: A. Shchekotikhin YS.


  1. 1. Fornier MN (2011) Approved agents for metastatic breast cancer. Semin Oncol 38: Suppl 2S3-10.
  2. 2. Jiang W, Lionberger R, Yu LX (2011) In vitro and in vivo characterizations of PEGylated liposomal doxorubicin. Bioanalysis 3: 333–344.
  3. 3. Ofran Y, Rowe JM (2011) Induction and postremission strategies in acute myeloid leukemia: what is new? Curr Opin Hematol 18: 83–88.
  4. 4. Haq I, Ladbury JE, Chowdhry BZ, Jenkins TC (1996) Molecular Anchoring of Duplex and Triplex DNA by Disubstituted Anthracene-9/10-diones: Calorimetric, UV Melting, and Competition Dialysis Studies. J Am Chem Soc 118: 10693–10701.
  5. 5. Agbandje M, Jenkins TC, McKenna R, Reszka AP, Neidle S (1992) Anthracene-9,10-diones as potential anticancer agents. Synthesis, DNA-binding, and biological studies on a series of 2,6-disubstituted derivatives. J Med Chem 35: 1418–1429.
  6. 6. Panousis C, Phillips DR (1994) DNA sequence specificity of mitoxantrone. Nucleic Acids Res 22: 1342–1345.
  7. 7. Hajihassan Z, Rabbani-Chadegani A (2009) Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins. J Biomed Sci 16: 31.
  8. 8. Fox KR, Polucci P, Jenkins TC, Neidle S (1995) A molecular anchor for stabilizing triple-helical DNA. Proc Natl Acad Sci U S A 92: 7887–7891.
  9. 9. Sun D, Thompson B, Cathers BE, Salazar M, Kerwin SM, et al. (1997) Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 40: 2113–2116.
  10. 10. Perry PJ, Gowan SM, Reszka AP, Polucci P, Jenkins TC, et al. (1998) 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. J Med Chem 41: 3253–3260.
  11. 11. Maizels N (2006) Dynamic roles for G4 DNA in the biology of eukaryotic cells. Nat Struct Mol Biol 13: 1055–1059.
  12. 12. Zahler AM, Williamson JR, Cech TR, Prescott DM (1991) Inhibition of telomerase by G-quartet DNA structures. Nature 350: 718–720.
  13. 13. Oganesian L, Moon IK, Bryan TM, Jarstfer MB (2006) Extension of G-quadruplex DNA by ciliate telomerase. EMBO J 25: 1148–1159.
  14. 14. Perry PJ, Reszka AP, Wood AA, Read MA, Gowan SM, et al. (1998) Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. J Med Chem 41: 4873–4884.
  15. 15. Andre F, Berrada N, Desmedt C (2010) Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients. Curr Opin Oncol 22: 547–551.
  16. 16. Broxterman HJ, Gotink KJ, Verheul HM (2009) Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. Drug Resist Updat 12: 114–126.
  17. 17. Sawyer DB, Peng X, Chen B, Pentassuglia L, Lim CC (2010) Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog Cardiovasc Dis 53: 105–113.
  18. 18. Novak RF, Kharash ED, Frank P, Runge-Morris M (1988) Anthracycline and anthracendione-based anticancer agents. In: Lown JW, editor. Bioactive molecules. Amsterdam: Elsevier Science Pub B.V. 519 p.
  19. 19. Shchekotikhin AE, Glazunova VA, Dezhenkova LG, Luzikov YN, Sinkevich YB, et al. (2009) Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones. Bioorg Med Chem 17: 1861–1869.
  20. 20. Tomasko M, Vorlickova M, Sagi J (2009) Substitution of adenine for guanine in the quadruplex-forming human telomere DNA sequence G3(T2AG3)3. Biochimie 91: 171–179.
  21. 21. Patel DJ, Phan AT, Kuryavyi V (2007) Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res 35: 7429–7455.
  22. 22. Chaires JB (2008) Calorimetry and thermodynamics in drug design. Annu Rev Biophys 37: 135–151.
  23. 23. Gray RD, Chaires JB (2008) Kinetics and mechanism of K+- and Na+-induced folding of models of human telomeric DNA into G-quadruplex structures. Nucleic Acids Res 36: 4191–4203.
  24. 24. Mergny JL, Phan AT, Lacroix L (1998) Following G-quartet formation by UV-spectroscopy. FEBS Lett 435: 74–78.
  25. 25. Gray DM, Wen JD, Gray CW, Repges R, Repges C, et al. (2008) Measured and calculated CD spectra of G-quartets stacked with the same or opposite polarities. Chirality 20: 431–440.
  26. 26. Phan AT, Kuryavyi V, Luu KN, Patel DJ (2007) Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution. Nucleic Acids Res 35: 6517–6525.
  27. 27. Chaires JB (2009) Human telomeric G-quadruplex: thermodynamic and kinetic studies of telomeric quadruplex stability. FEBS J 277: 1098–1106.
  28. 28. Wang Y, Patel DJ (1993) Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure 1: 263–282.
  29. 29. Balasubramanian S, Neidle S (2009) G-quadruplex nucleic acids as therapeutic targets. Curr Opin Chem Biol 13: 345–353.
  30. 30. Huppert JL (2008) Hunting G-quadruplexes. Biochimie 90: 1140–1148.